Our results indicate that Z-VAD-FMK inhibits the decrease of cell viability and the increase of LDH cytotoxicity and caspase-3 activity caused by PB01 in NSCLC cells (Fig. 2e–g). Here, CASP3 is linked to non-small cell lung carcinoma.